Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antigoni Lekka

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 20, 2019
Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?George Sotiropoulos, Marianna Kotopouli, Irene Karampela, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancerGeorge P Sotiropoulos, Maria Dalamaga, Georgios Antonakos, et al.
Cancer Causes & Control : CCC|May 11, 2010
B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in GreeceMaria Dalamaga, Bradley H Crotty, Jessica Fargnoli, et al.
Biomolecules|November 27, 2021
Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional StudyGerasimos Socrates Christodoulatos, Georgios Antonakos, Irene Karampela, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 20, 2019
Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?George Sotiropoulos, Marianna Kotopouli, Irene Karampela, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancerGeorge P Sotiropoulos, Maria Dalamaga, Georgios Antonakos, et al.
Cancer Causes & Control : CCC|May 11, 2010
B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in GreeceMaria Dalamaga, Bradley H Crotty, Jessica Fargnoli, et al.
Biomolecules|November 27, 2021
Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional StudyGerasimos Socrates Christodoulatos, Georgios Antonakos, Irene Karampela, et al.
Pageof 2